IASO's brand Gamuqi electronic cigarette was developed in response to the foreign demand of this era. Designed for high-end markets in Europe and America, it is mainly aimed at people who can't throw away cigarettes due to work and perennial living habits, have higher requirements on quality of life, pay more attention to their own health and the health of others, and advocate low-carbon and environmentally-friendly life.
In view of IASO's technical accumulation and market demand in the medical field, as well as its social responsibility in environmental sanitation, GAMUCCI e-cigarettes came into being in London, England in 2007, and successfully seized the European and American markets.
2065438+June 2002, British IASO Group refined the market and further adjusted the e-cigarette brand. Gamucci has become a second-class series, and the classic, elite and micro departments are independent. High-end series all use IASO snake labels to show identity differentiation. In view of the current situation of domestic smoking cessation market, the quality of products is mixed, the price is expensive and there are many false propaganda.
To this end, IASO has always adhered to the social responsibility and scientific attitude that a medical device enterprise should have, and strictly stated:
"To fundamentally quit tobacco dependence, we must rely on our own willpower, and no drug or commodity can play a decisive role."